DC Drug Testing Laws for Employers
The District has one of the most protective cannabis employment statutes in the country. It also has a live question about whether that statute is actually in force — and the answer you will find in most published guidance does not match what the official code says.
Start With What Is Certain
The District has no comprehensive statute on testing mechanics — nothing on policy contents, collection or laboratory standards, medical review officer involvement, confirmation testing, retest rights or result-notification deadlines. It has two cannabis-specific enactments, and one of them is not in doubt.
D.C. Code 32-931(a), in force since July 22, 2015, provides that an employer may only test a prospective employee for marijuana use after a conditional offer of employment has been extended, unless otherwise required by law.
That is a sequencing rule, not a prohibition. Screening for other substances before an offer is not restricted by the chapter, and section 32-931(b) preserves a good deal: employee compliance with workplace drug policies is unaffected; no employer must permit or accommodate use, consumption, possession, transfer, display, transportation, sale or growing of marijuana in the workplace or at any time during employment; federal employment contracts are not interfered with; and the employer may still deny a position based on a positive test for marijuana.
Two scope points. There is no employee-count threshold. And, contrary to a claim that recurs in secondary summaries, the text carries no exception for police or special police officers, law-enforcement-function positions, or CDL holders. If you need one, you are relying on "unless otherwise required by law" for genuinely federally mandated testing.
Operationally this is easy to get wrong: a national applicant panel that includes THC and is ordered at the time of application rather than after the conditional offer means the District requisition has to be split out.
Employing people in the District?Five questions, about a minute. A specialist follows up within one business day.
Request a SpecialistThe Unsettled Part
Title I of D.C. Law 24-190, the Cannabis Employment Protections Amendment Act of 2022, created Chapter 9B of Title 32. It goes much further than the 2015 provision.
Here is the problem. The official D.C. Code, as published by the Council's Law Library, displays the substantive sections of Chapter 9B as "Not Funded," with an applicability note stating the amendment has not been implemented. That covers the employment protections, the rules of construction, the notice provisions, the OHR complaint route, the private action, the Attorney General enforcement provision, the rulemaking authority, and the companion Human Rights Act amendment at 2-1402.11(b-1). Only the definitions section is shown in force.
The cause is section 401(a)(2) of the law itself: those sections apply upon the date of inclusion of their fiscal effect in an approved budget and financial plan, or 365 days after the Mayor approves the act, whichever is later. The D.C. Office of Human Rights independently lists the Act among laws that have been passed but are awaiting funding in order to be enforced by OHR.
Virtually all published third-party guidance says the law took effect July 13, 2023. That is the 365-day date, and it ignores the budget condition.
We are not going to resolve this. Both facts are stated above with their sources, and whether Chapter 9B is enforceable despite the appropriations condition is a legal question for District counsel rather than a drafting question. What we will say is what a careful employer should do about it.
The Sensible Response: Comply As If It Is Operative
The asymmetry favors compliance. The cost of building to Chapter 9B is a written designation exercise and a notice; the cost of being wrong the other way is a penalty regime reaching $5,000 per violation, doubled for repeat violations, plus a private right of action. So here is what the chapter would require.
The core protection. Section 32-951.02(a) would bar an employer from refusing to hire, terminating, suspending, failing to promote, demoting or penalizing an individual based on cannabis use, status as a medical cannabis program patient, or the presence of cannabinoid metabolites in a drug test without additional factors indicating impairment. That third prong reaches the test result itself, which is what separates this jurisdiction from ordinary off-duty-use statutes.
Four exceptions. The position is designated safety sensitive; the action is required by federal statute, regulation, contract or funding agreement; the employee used, possessed, stored, delivered, transferred, displayed, transported, sold, purchased or grew cannabis at the place of employment, while performing work, or during work hours; or the employee is impaired as the statute defines it.
Safety-sensitive is employer-designated, under section 32-951.01(8), covering positions where it is reasonably foreseeable that performing routine duties under the influence would likely cause actual, immediate and serious bodily injury or loss of life. Seven categories are enumerated: security services including police, special police and security officers, and custody or use of weapons including firearms; regular or frequent operation of a motor vehicle, heavy or dangerous equipment or machinery; regular or frequent work on an active construction site or occupational safety training; regular or frequent work on or near power or gas utility lines; regular or frequent handling of hazardous materials; supervision or routine care of individuals unable to care for themselves in an institutional or custodial environment; and administering medications, performing or supervising surgeries, or providing other medical treatment requiring professional credentials.
Notice. Section 32-951.04(a) would require notice of rights, safety-sensitive designations and testing protocols within 60 days, annually thereafter, and on hire.
Enforcement. Penalty tiers run to $1,000, $2,500 and $5,000 per violation at 1 to 30, 31 to 99, and 100 or more employees respectively, doubled for a repeat violation within the previous year, with half payable to the complainant. The OHR complaint deadline and the private action deadline are each one year, with exhaustion required unless the employee is a medical cannabis program patient. There is no employee-count coverage threshold — headcount affects only the size of the penalty.
Note what the rules of construction do and do not preserve. Section 32-951.03(2)(A) would preserve post-accident, reasonable-suspicion and safety-sensitive testing — but does not mention random cannabis testing of non-safety-sensitive employees.
Do Not Import a Cutoff-Based Impairment Standard
The District's impairment definition is behavioral and observational, not numerical. There is no cutoff level that establishes impairment here. Supervisors need training to document specific articulable symptoms contemporaneously, because that documentation is the exception you would be relying on.
That is a different habit from the one most programs have, where the laboratory result does the work and the supervisor note is a formality.
Workers' Compensation Gives You Almost Nothing
D.C. Code 32-1503(d) denies compensation only where injury to the employee was occasioned solely by intoxication or by willful intention to injure or kill. The word "solely" does the work, and there is no statutory testing presumption, no per se cutoff, no authorization to compel a post-accident test and no forfeiture for refusing one.
On unemployment, D.C. Code 51-110(b) disqualifies for gross misconduct and imposes a shorter disqualification for other misconduct, but the statute contains no drug- or drug-test-specific definition, so that question is resolved by regulation and agency decision rather than by the code.
The practical conclusion: a District post-accident program earns its keep through your own policy and through federal requirements, not through compensation leverage.
Where This Lands
The District's employment base is dominated by federal government and government contracting, professional, scientific and technical services, hospital systems, hospitality and restaurants, higher education and research, and construction and building services. Government contracting is the saving grace here: federal requirements are preserved under both enactments, so DOT-regulated drivers, federal contractor roles and security-clearance positions should be clearly identified and kept separate. For the hospitality and professional services populations, the metabolite rule is the one to plan around.
Common questions
What is definitely in force in the District?
The pre-employment sequencing rule. D.C. Code 32-931(a), in force since July 22, 2015, provides that an employer may only test a prospective employee for marijuana use after a conditional offer of employment has been extended, unless otherwise required by law.
Can we still deny the position on a positive?
Under Chapter 9A, yes. Section 32-931(b)(4) expressly preserves the employer's ability to deny a position based on a positive test for marijuana. The chapter regulates when you may test an applicant, not what you may conclude from the result. Chapter 9B, if treated as operative, would add a second layer at the hiring stage.
Is there a CDL or police exception to the pre-offer rule?
Not in the text, and this recurs in secondary summaries. Section 32-931 contains no exception for police or special police officers, for positions with a law enforcement function, or for positions requiring a commercial driver's license. The only textual escape hatches are "unless otherwise required by law" in subsection (a) and the federal employment contract clause in subsection (b)(3).
Is the Cannabis Employment Protections Act in effect?
That is genuinely unsettled, and it is the single most important fact about this jurisdiction. The official D.C. Code published by the Council's Law Library displays the substantive sections of Chapter 9B — and the companion Human Rights Act amendment — as "Not Funded" and as not implemented. Only the definitions section is shown in force. The D.C. Office of Human Rights separately lists the Act among laws passed but awaiting funding in order to be enforced.
But guidance says it took effect in July 2023?
That date comes from one half of a two-part condition. Section 401(a)(2) of D.C. Law 24-190 provides that those sections apply upon the date of inclusion of their fiscal effect in an approved budget and financial plan, or 365 days after the Mayor approved the act, whichever is later. July 13, 2023 is the 365-day date. Summaries citing it as the effective date are reading past the budget condition. We are reporting both facts rather than picking one — this is a question for District counsel.
Sort Out Your District Requisitions
Request a testing specialist
Answer five quick questions. There is no cost and no obligation.
Sources and review
- D.C. Code 32-931, restriction on pre-employment marijuana testing
- D.C. Code Title 32, Chapter 9B, Cannabis Employment Protections
- D.C. Code 32-951.01, definitions including safety sensitive
- D.C. Code 32-951.02, employment protections (shown Not Funded)
- D.C. Code 32-951.04, notice of rights under the law
- D.C. Law 24-190, Cannabis Employment Protections Amendment Act of 2022, including the section 401 applicability condition
- D.C. Code 2-1402.11, Human Rights Act employment prohibitions (subsection (b-1) shown Not Funded)
- D.C. Code 32-1503, workers' compensation coverage and intoxication defense
- D.C. Office of Human Rights, local human rights laws (lists the Act as awaiting funding)
This page is general information about employer drug testing, not legal advice. Drug testing rules differ by state and by industry. Check with your own counsel before setting or changing a testing policy.